Otolaryngology
Ear, nose & throat clinical trials
Hearing, balance, and conditions of the ears, nose, sinuses, and throat. We’re tracking 1,371 recruiting studies in this area right now.
By phase
- Not applicable978
- Phase 2168
- Phase 399
- Phase 146
- Phase 434
- Phase 1/Phase 232
- Phase 2/Phase 314
Top conditions
- Nasopharyngeal Carcinoma80
- Dysphagia73
- Hearing Loss61
- Tinnitus31
- Hearing Loss, Sensorineural25
- Nasopharyngeal Carcinoma (NPC)24
- Allergic Rhinitis23
- Head and Neck Cancer22
- Oropharynx Cancer21
- Stroke20
- Sensorineural Hearing Loss18
- Nasopharyngeal Cancinoma (NPC)17
- Chronic Rhinosinusitis With Nasal Polyps15
- Oropharyngeal Cancer15
- Nasopharyngeal Cancer14
- Vestibular Schwannoma14
- Head and Neck Squamous Cell Carcinoma13
- Chronic Rhinosinusitis (CRS)12
Leading sponsors
- Sun Yat-sen University59
- Eye & ENT Hospital of Fudan University17
- Cairo University15
- Assistance Publique - Hôpitaux de Paris14
- NYU Langone Health14
- Mayo Clinic12
- National Cancer Institute (NCI)12
- Johns Hopkins University11
- Ming-Yuan Chen11
- Cochlear9
Where studies are running
- California62
- Maryland37
- New York35
- Florida30
- Massachusetts21
- Illinois20
- Texas18
- Arizona17
- Colorado16
- Alabama15
Recruiting studies1,371 total
- NCT05586763RecruitingPhase 3
Compare anti-nausea medicines for short-term vertigo
This trial tests whether metoclopramide, promethazine, or prochlorperazine works best to reduce nausea and symptoms during a new episode of vertigo. It may help you find the most effective medicine for acute peripheral vertigo with nausea or vomiting.
MuscatAges 18–60 - NCT05587543RecruitingEarly Phase 1
Test of EBV CAR-T or TCR-T cells for nasopharyngeal cancer
This early-phase study tests personalized immune cells (EBV CAR-T or TCR-T) to treat nasopharyngeal cancer that has returned or spread. It aims to help the immune system find and attack the cancer after other treatments have not worked.
ShanghaiAges 18–75 - NCT05591040Recruiting
Biofeedback to help swallow problems after stroke
This trial studies whether using “biofeedback” (seeing your body’s muscle signals on a screen) along with standard care can improve swallowing after a stroke. You might be eligible if you have ongoing swallow trouble and can safely do the training sessions.
Venice-LidoAges 18–89 - NCT05593484Recruiting
School hearing screenings with telemedicine referral
This trial helps check children’s hearing at participating schools in rural Alaska, and then connects families with specialty care by video (telemedicine) if needed. It may help children get faster evaluation and support for hearing problems.
Anchorage, AlaskaAges 3–21 - NCT05603897Recruiting
Testing dysphagia screening methods after recent stroke
This study compares two ways of checking for swallowing problems (dysphagia) in people who were recently hospitalized for an acute ischemic stroke. If the new screening method works better, it could help catch swallowing issues earlier and improve safety.
Miami, FloridaAges 18 years+ - NCT05607888Recruiting
Study of treatment for sinus and skull-base tumors
This study looks at how doctors manage tumors that start in the nose/sinuses and spread to the skull base. It may help improve planning of care for people with this specific type and location of tumor.
Ljubljana, LjubljanaAges Any age - NCT05614375Recruiting
Endoscopic surgery for soft tissue cancer in the nose
This trial studies using a minimally invasive camera-assisted surgery to remove soft tissue sarcoma in the nose and nearby sinuses. It may help by aiming to fully remove the tumor safely while considering how well patients’ bodies can handle surgery.
Shanghai, Shanghai MunicipalityAges Any age - NCT05622344Recruiting
Neurofeedback training to improve balance in vestibular schwannoma
This study tests whether brain “neurofeedback” training, along with a balance rehab plan, can help people with dizziness/balance symptoms from unilateral vestibular schwannoma. You may qualify if you can follow the study schedule and safely move your head and walk during testing.
Baltimore, MarylandAges 21–70 - NCT05621889RecruitingPhase 1/Phase 2
Virtual speech therapy program for head and neck cancer patients
This trial tests a partner-guided virtual speech therapy program delivered through group sessions and questionnaires for people with head and neck cancer. If you’re starting curative chemo-radiation, the program may help with speech and swallowing-related symptoms during treatment.
Montreal, QuebecAges 18 years+ - NCT05628922RecruitingPhase 2
Blood EBV DNA–guided therapy for advanced nasopharyngeal cancer
This trial tests a treatment approach for people with locally advanced nasopharyngeal cancer using their blood EBV DNA level (a cancer-related virus marker). It may help doctors choose and adjust therapy based on how much of this marker is in your blood after standard treatment.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT05629325RecruitingPhase 4
Buspirone for weak or missing esophagus contractions
This study tests whether buspirone helps people whose esophagus does not squeeze properly (or doesn’t squeeze at all), causing swallowing problems. You would be assigned to buspirone or a placebo and monitored to see if symptoms improve.
Leuven, Vlaams-BrabantAges 18 years+ - NCT05634356Recruiting
Study of how early speech learning changes with social input
This study looks at how infants learn speech sounds through everyday social interaction, like parent talk. It may help researchers understand what supports early speech development, including in babies with typical hearing and those with hearing loss or hearing devices.
Los Angeles, CaliforniaAges 7 months–2 years - NCT05638269Recruiting
Study of gut bacteria in people with serious long-term illness
This study looks at the types of gut bacteria in people living in certain parts of China who have serious long-term (chronic) illnesses. The goal is to better understand how gut bacteria differ and may help doctors in the future tailor care.
Chaoyang, Beijing MunicipalityAges 18–75 - NCT05639972RecruitingPhase 1/Phase 2
HPV cancer trial using immune T cells made for you
This Phase 1/2 trial tests a one-time infusion of special immune T cells made to recognize your HPV16 tumor. It may help your body attack the cancer, while researchers closely monitor safety and early effectiveness.
New Brunswick, New JerseyAges 18 years+ - NCT05641142Recruiting
Testing blood thinners in adults with inherited bleeding vessel disease
This study looks at people with Rendu-Osler (hereditary hemorrhagic telangiectasia) who have just started blood-thinning medicines. It aims to understand how antiplatelet and/or anticoagulant therapy affects safety and outcomes soon after starting.
AngersAges 18 years+ - NCT05641441Recruiting
Study hearing side effects after targeted treatment for vestibular schwannoma
This study looks at how targeted brain/skull-base treatment for a vestibular schwannoma may affect hearing (ear “ototoxicity,” meaning damage to hearing). It may help doctors better predict and prevent hearing problems in people treated for this tumor.
GenevaAges 18 years+ - NCT05656365Recruiting
Study of genes and immunity in PFAPA and other tonsil problems
This study looks at genetic markers and immune system patterns in people with PFAPA (periodic fevers with mouth sores and throat/neck gland symptoms) or similar tonsil problems. It may help researchers understand why these conditions happen and how they might be better diagnosed or treated.
Washington D.C., District of ColumbiaAges 1 month–99 years - NCT05668338Recruiting
Hearing-device registry study for MED-EL users
This is an observational study that collects information from people using MED-EL hearing devices (with or without an implant) to better understand real-world hearing care. It may help improve future planning, support, and device use for patients like you.
BochumAges Any age - NCT05670158Recruiting
Testing blood immune markers after cochlear implantation
This study compares blood and fluid-related immune “profiles” after cochlear implant surgery versus another ear/middle-ear surgery group. It aims to learn which immune signals may be linked to hearing outcomes and recovery after implantation.
MontpellierAges 18 years+ - NCT05674305RecruitingPhase 3
Tested radiation alone vs added chemotherapy for EBV-negative after treatment
This Phase 3 trial compares giving radiation alone versus giving radiation at the same time as chemotherapy for nasopharyngeal cancer. It focuses on people whose EBV test becomes undetectable after one cycle of chemotherapy, to see which approach works best and is safest.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT05674786Recruiting
Implant to help adults with severe balance nerve loss
This study tests whether a vestibular (balance) implant can improve balance and eye-stabilizing reflexes in adults with severe loss of balance function in both inner ears. You may benefit if long-term balance therapy has not helped enough.
Baltimore, MarylandAges 22–90 - NCT05676944Recruiting
Cochlear-like implant to help balance in older adults
This study tests a surgically placed implant aimed at improving balance and eye-stabilizing reflexes in older adults who have long-lasting, hard-to-treat inner-ear balance problems. You may be able to help researchers learn whether the device plus training can reduce dizziness and improve movement stability.
Baltimore, MarylandAges 65–90 - NCT05679271Recruiting
Stent treatment for low-grade dural AV fistula causing ringing
This trial tests whether placing a small tube (stent) inside a brain vein-sinus can reduce a pulsating ringing sound caused by a “dural arteriovenous fistula” (DAVF). It’s for people whose tinnitus matches the DAVF location and who meet imaging and medication safety requirements.
BordeauxAges 18 years+ - NCT05686226RecruitingPhase 2
Trial tests immune cells targeting HPV-16 cancers
This Phase 2 trial tests an immune-cell treatment (E7 TCR T cells) designed to attack cancers caused by HPV type 16. It may help people whose HPV-16+ cancer has come back or not responded to standard treatment.
Bethesda, MarylandAges 18 years+
Common questions
- How many ear, nose & throat clinical trials are recruiting?
- Clin2 is tracking 1,371 recruiting otolaryngology studies from the U.S. registry right now, out of 2,216 we cover in this area in total.
- What does “Ear, nose & throat” cover here?
- Hearing, balance, and conditions of the ears, nose, sinuses, and throat. We group each study into ear, nose & throat based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a ear, nose & throat trial near me?
- Use the search to filter ear, nose & throat studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.